Free Trial

Dermata Therapeutics (DRMAW) Competitors

$0.02 -0.01 (-26.70%)
As of 10/3/2025 03:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DRMAW vs. ATNFW, LBPSW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CALA, and CELUW

Should you be buying Dermata Therapeutics stock or one of its competitors? The main competitors of Dermata Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Dermata Therapeutics vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Dermata Therapeutics (NASDAQ:DRMAW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

In the previous week, Dermata Therapeutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Dermata Therapeutics and 0 mentions for 180 Life Sciences. Dermata Therapeutics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that Dermata Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
180 Life Sciences Neutral
Dermata Therapeutics Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Dermata TherapeuticsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Dermata Therapeutics N/A N/A N/A

Summary

Dermata Therapeutics beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Get Dermata Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRMAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRMAW vs. The Competition

MetricDermata TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$234.86M$6.05B$10.58B
Dividend YieldN/A3.80%5.68%4.69%
P/E RatioN/A30.9377.3326.67
Price / SalesN/A6,032.76606.81133.76
Price / CashN/A13.1937.7361.25
Price / BookN/A107.2612.556.55
Net IncomeN/A-$90.99M$3.30B$277.26M
7 Day PerformanceN/A4.25%28,056.13%2.37%
1 Month PerformanceN/A7.67%28,993.65%9.30%
1 Year PerformanceN/A600.15%35,460.84%30.78%

Dermata Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRMAW
Dermata Therapeutics
N/A$0.02
-26.7%
N/AN/A$0.00N/A0.008Positive News
Short Interest ↓
ATNFW
180 Life Sciences
N/A$0.07
-13.1%
N/A+776.8%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AIMDW
Ainos
N/A$0.17
+25.3%
N/A+201.7%$0.00$110.87K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.50
-7.3%
N/AN/A$0.00$560.10M0.004Positive News
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
-29.8%
N/AN/A$0.00N/A0.0015Gap Down
BFRIW
Biofrontera
N/A$0.10
+3.1%
N/A+270.0%$0.00$39.19M0.0070Positive News
BTMDW
biote
N/A$0.01
-2.1%
N/AN/A$0.00$199.07M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.03
-17.3%
N/A-88.0%$0.00N/A0.008Short Interest ↑
Gap Up
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-90.0%$0.00N/A0.0060
CELUW
Celularity
N/A$0.05
-9.8%
N/A+299.0%$0.00$44.59M0.00220Positive News
Short Interest ↓
Gap Down

Related Companies and Tools


This page (NASDAQ:DRMAW) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners